ArticleScientific reports2026
Hydration-stable PVA-based skin phantom for wearable biopotential sensor evaluation.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The development of biomimetic skin phantoms is critical for reliable biopotential measurements in wearable sensor applications. A major limitation is hydration instability, as moisture loss alters ionic conductivity and leads to unpredictable impedance behavior. Building on prior work using polyvinyl alcohol (PVA) cryogels as benchtop analogs for electrode evaluation, this study investigates hydrophilic additive integration and freeze-thaw processing as complementary strategies to improve hydration retention and electrical stability. Seven commercial hydrophilic additives were screened for their ability to reduce mass loss and stabilize impedance over time. Aloe Vera proved most effective, reducing mass loss and impedance variability and extending phantom electrical lifespan from approximately 4 days for untreated controls to up to 18 days under optimized conditions. Embedded additive testing identified an optimal concentration of approximately 0.75 g (5.5--6.5% w/w), while higher concentrations produced oversaturation and electrical drift. Freeze-thaw optimization demonstrated that a single cycle preserved structural integrity and minimized dehydration, whereas repeated cycling (≥ 2 cycles) increased mass loss, permittivity decay, and electrical instability. Differential scanning calorimetry quantified the distribution of freezable and bound water within the cryogel matrix. Samples containing the additive exhibited markedly reduced endothermic peak magnitudes during melting, indicating a lower fraction of freezable water and a corresponding increase in tightly bound water. These results establish a combined chemical-physical framework that extends phantom functional lifespan by more than fourfold and provides long-term hydration stability and consistent impedance behavior suitable for repeatable wearable biosensor testing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.